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Mouse embryonic stem cells (ESCs) are maintained
in a naive ground state of pluripotency in the pres-
ence of MEK and GSK3 inhibitors. Here, we show
that ground-state ESCs express low Myc levels.
Deletion of both c-myc and N-myc (dKO) or pharma-
cological inhibition of Myc activity strongly de-
creases transcription, splicing, and protein synthe-
sis, leading to proliferation arrest. This process is
reversible and occurs without affecting pluripotency,
suggesting that Myc-depleted stem cells enter a
state of dormancy similar to embryonic diapause.
Indeed, c-Myc is depleted in diapaused blastocysts,
and the differential expression signatures of dKO
ESCs and diapaused epiblasts are remarkably
similar. Following Myc inhibition, pre-implantation
blastocysts enter biosynthetic dormancy but can
progress through their normal developmental pro-
gram after transfer into pseudo-pregnant recipients.
Our study shows that Myc controls the biosynthetic
machinery of stem cells without affecting their po-
tency, thus regulating their entry and exit from the
dormant state.668 Cell 164, 668–680, February 11, 2016 ª2016 The AuthorsINTRODUCTION
The Myc family of transcription factors comprises c-Myc,
N-Myc, and L-Myc and has been implicated in the generation
of a variety of human tumors. Enhanced Myc expression has
been shown to contribute to several aspects of tumorigenesis
(Adhikary and Eilers, 2005) including unrestricted proliferation
(Eilers et al., 1991), inhibition of differentiation (Freytag and
Geddes, 1992), cell growth and metabolism (Dang, 2013; Iritani
and Eisenman, 1999; Johnston et al., 1999), reduction of cell
adhesion (Arnold and Watt, 2001), and metastasis (Pelengaris
et al., 2002). The role of Myc proteins in development has been
widely investigated making use of gene targeting in mice:
whereas L-myc knockout mice develop normally (Hatton et al.,
1996), embryos lacking c-myc die before E10.5 due to hemato-
poietic and placental defects (Dubois et al., 2008; Trumpp et al.,
2001), andN-myc-deficient embryos die before E11.5 displaying
neuroectodermal and heart defects (Charron et al., 1992). Myc
activity is essential for efficient cellular reprogramming (Wernig
et al., 2008) and has complex roles in various stem and progen-
itor cell types (Laurenti et al., 2009). In the adult hematopoietic
system, c-Myc controls the balance between hematopoietic
stem cell (HSC) self-renewal and differentiation by regulating
the interaction between HSCs and their niche (Wilson et al.,
2004). Interestingly, only the highly quiescent, dormant HSCs
survive the simultaneous deletion of both c-myc and N-myc in
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Figure 1. Myc Is Required for Proliferation but Not for Maintenance of the Core Pluripotency Network in 2i-Cultured ESCs
(A and B) Ground-state ESCs express low levels of Myc.
(A) Mouse ESCs were cultured for more than eight passages in 2i or serum and c-myc and N-myc expression were quantified by qRT-PCR analysis and
normalized to Gapdh. Values are shown as mean ± SEM.; n = 3.
(B) Flow cytometry analysis of eGFP-c-Myc expression in c-MyceGFP/eGFP reporter ESCs cultured for 72 hr in serum (red) or in 2i (blue). The gray histogram
represents the autofluorescence signal from ESCs not expressing the eGFP-c-Myc reporter protein. Experiments were performed in triplicates, and values
represent geometrical mean (Geo Mean) ± SD.
(C) c-MYC expression levels in H9 human ESCs and H9-reset cells. Bar graphs show FPKM (fragments per kilobase of exon per million reads mapped) values of
three replicates and are represented as mean ± SD. Data are from Takashima et al. (2014).
(D–L) dKO ESCs undergo cell-cycle arrest but maintain the expression of the core pluripotency factors.
(D) Experimental workflow. c-mycD/D; N-mycD/flESCswere transfectedwith an EF1a-mCherry-Cre plasmid and sorted 24 hr later asmCherry negative (c-mycD/D;
N-mycD/fl) and positive (dKO) cells. Sorted cells were plated in 2i medium and analyzed 72 hr after sort.
(legend continued on next page)
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the hematopoietic system, while all the other hematopoietic cells
are rapidly lost due to impaired proliferation, differentiation, and
overt apoptosis (Laurenti et al., 2008, 2009). In ESCs grown in
serum plus LIF (hereafter referred to as serum), Myc proteins
have been suggested to sustain pluripotency by repressing the
primitive endoderm master regulator Gata6 and to contribute
to cell-cycle control by regulating the mir-17-92 miRNA cluster
(Smith et al., 2010; Varlakhanova et al., 2010). However, ESCs
cultured in serum exhibit heterogeneous expression of pluripo-
tency markers, and only a fraction of these cells correlate with
the pre-implantation epiblast, as shown by transcriptional
profiling (Boroviak et al., 2014; Marks et al., 2012; Ying et al.,
2008). In contrast, ESCs cultured in 2i plus LIF (hereafter referred
to as 2i) are captured in a naive ground state of pluripotency and
retain the essential features of the pluripotent epiblast cells (Bor-
oviak et al., 2014). The precise function of Myc in naive ground-
state ESCs and the role of Myc in the mouse epiblast remain
elusive. Here, we use a combination of genetic, transcriptomic,
and cellular analyses to show that Myc activity reversibly con-
trols the biosynthetic and proliferative machineries of ground-
state naive ESCs without affecting pluripotency and link these
data on ESCs to the physiological status of dormant, diapaused
embryos.
RESULTS
Myc Is Essential for Proliferation but Not for
Maintenance of the Core Pluripotency Network in
Ground-State ESCs
Mouse ESCs cultured in serum express significantly higher levels
of c-myc and N-myc transcripts compared to ESCs grown in 2i
(Figure 1A) (Marks et al., 2012). In agreement with this observa-
tion, a lower expression of c-Mycprotein in 2i compared to serum
wasobservedby flowcytometry usinga c-MyceGFP knockin allele
(Figure 1B) (Huang et al., 2008). Lower expression of c-MYC tran-
scripts was also observed in humanH9 ESCs that were reset to a
naive state of pluripotency compared to their primed counter-
parts (Figure 1C) (Takashima et al., 2014). To genetically explore
the function of Myc in naive ground-state ESCs, we derived ESC
lines from mice homozygous for the c-myc and N-myc floxed al-
leles (c-mycfl/fl; N-mycfl/fl) (Knoepfler et al., 2002; Trumpp et al.,
2001) as well as the Cre reporter gene Rosa26lox-stop-loxEYFP (Sri-
nivas et al., 2001). All generated ESC lines had the capacity to
differentiate into tissues derived from all three germ layers both
in vitro and in vivo (Figures S1A and S1B). To induce the genera-
tion of c-myc and N-myc-null alleles (c-mycD and N-mycD,
respectively), we transiently transfected c-mycfl/fl; N-mycfl/fl;(E) Phase-contrast microscopy images showing the typical morphology of dKO E
(F) Representative flow cytometry plots of the cell-cycle profiles of c-mycD/D; N-my
to distinguish apoptotic (sub-G1) cells and cells in the G0/G1, S or G2/M phases.
(G) Quantitative analysis of the different cell-cycle phases as gated in (F). The ba
(H) Percentage of cells in the G0 phase (Hoechst low and intracellular Ki67
neg) of
SEM; n = 6.
(I) Quantitative analysis of apoptotic cells (sub-G1) as gated in (F). Values are sh
(J) Percentage of ESCs expressing cleaved Caspase 3, as assessed by flow cytom
represent mean ± SD; n = 3.
(K) Alkaline phosphatase activity of c-mycD/D; N-mycD/fl and dKO cells cultured i
(L) Representative fluorescence staining showing Oct4 and Nanog expression in
670 Cell 164, 668–680, February 11, 2016 ª2016 The AuthorsRosa26lox-stop-loxEYFP ESCs with a plasmid encoding a Cre re-
combinase and fluorescence-activated cell-sorted (FACS)
EYFP+ cells followed by plating in 2i medium and expansion of
single clones (Figure S1C). Although we could establish 102
clonal cell lines, no c-myc/N-myc double knockout (dKO) ESC
clones could be derived, as all lines retained at least one allele
of either c-mycfl or N-mycfl (Figures S1D and S1E). Single KO
ESCs did not show any detectable phenotype as they formed
dome-shaped colonies and were capable of multilineage differ-
entiation both in vitro and in vivo (Figures S1F and S1G). These
data show that neither c-myc nor N-myc alone are required for
ESC maintenance in 2i and suggest functional redundancy be-
tween the two genes. To additionally eliminate the fourth ‘‘fl’’
allele, c-mycD/D; N-mycD/flESCswere transfectedwith a plasmid
coding for an EF1a-driven mCherry-Cre fusion protein and
mCherry positive (Cre+) and negative (Cre–) cells were FACS
sorted and cultured in 2i (Figure 1D). We confirmed dKO ESCs
in the Cre+ population 24 and 96 hr after transfection using both
PCR and qRT-PCR analysis (Figures S1H and S1I). FACS anal-
ysis of the cell cycle showed that single deletion of either c-myc
or N-myc did not affect the proliferative status of naive ground-
state ESCs (Figure S1J). In contrast, 96 hr after Cre induction
dKO ESCs ceased to proliferate and formed very small, dome-
shaped colonies (Figure 1E). This was associated with the com-
plete absence of DNA synthesis (Figures 1F and 1G), an increase
in G0 arrested cells (Figure 1H), and a fraction of dKO ESCs un-
dergoing apoptosis (Figures 1I, 1J, and S1K). These data demon-
strate that, even in 2i conditions, low levels of c-MycorN-Myc are
required to prevent cell-cycle arrest of ground-state ESCs. Next,
we addressed whether Myc-mediated cell-cycle arrest influ-
ences pluripotency and lineage differentiation. In 2i, both single
KO and dKO ESCs expressed alkaline phosphatase (Figure 1K)
and unexpectedly also displayed similar levels of Nanog, Oct4,
and Sox2 (Figures 1L and S1L–S1M). These data provide evi-
dence that c/N-Myc activity is specifically required for prolifera-
tion but dispensable for the expression of the core pluripotency
factors in naive ground-state ESCs.
Loss ofMyc inGround-State ESCs Leads to Biosynthetic
Quiescence
To further explore the consequences of c/N-myc deletion, we
sequenced the transcriptome of ESCs 24 and 96 hr after Cre in-
duction (Figures 2A and S2A; Table S1; Data S1). As expected,
c-myc and N-myc downregulation was confirmed at both time
points in the transcriptome data (Figure S2B). In line with the
immunohistochemistry observations (Figure 1L), the transcript
levels of the core and extended pluripotency networks (e.g.,SCs. Scale bar, 100 mm.
cD/fl and dKO ESCs. Incorporated BrdU and total DNA content (7AAD) are used
r charts indicate the mean ± SD; n = 4.
the cell cycle as assessed by flow cytometry. Bar graphs indicate the mean ±
own as mean ± SEM; n = 4.
etry. ESCs incubated for 10 min at 42Cwere used as positive control. Values
n 2i. Scale bar, 20 mm.
ESCs cultured in 2i. Scale bar, 50 mm.
AB
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Figure 2. Loss of Myc Activity Induces Cellular Dormancy in ESCs Cultured in 2i
(A) Workflow of the RNA-seq analysis. Untransfected c-mycfl/fl; N-mycfl/fl (sample 1) and c-mycD/D; N-mycD/fl (sample 2) were used as controls. c-mycD/D;
N-mycD/fl cells were transfected with an EF1a-mCherry-Cre plasmid and sorted 24 hr later as Cre negative (c-mycD/D; N-mycD/fl) and positive (dKO) cells. The
samples were analyzed immediately after sort (24 hr after Cre transfection, samples 3 and 5) or plated in 2i and analyzed 72 hr after sort (96 hr after Cre
transfection, samples 4 and 6). For each condition, two biological replicates in independent experiments were sequenced and analyzed.
(B) Heatmap representation of the mean number of sequenced fragments for the genes belonging to the different pluripotency and commitment gene signatures
as defined byMarks et al. (2012). PL, pluripotency; PL2, extended pluripotency; GL, germline; ED, endoderm; EC, ectoderm;MS, mesoderm. A gene differentially
expressed in at least one sample compared to another condition is indicated by an asterisk (FDR = 0.1).
(C) Overrepresented Gene Ontology (GO) categories in the genes progressively (at 24 and 96 hr; cluster 44) and lately (at 96 hr; cluster 48) downregulated in
dKO ESCs.
(legend continued on next page)
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Zfp42, Nanog, Pou5f1 [Oct4], Esrrb, Tbx3) remained unaltered in
dKO ground-state ESCs (Figures 2B and S2C) (Marks et al.,
2012). Lineage-specific differentiation genes (germline, ecto-
derm, endoderm, and mesoderm) were mostly not upregulated
(Figure 2B), demonstrating that arrested dKO ground-state
ESCs maintain expression of the pluripotency network without
upregulation of differentiation signatures. To identify genes and
processes regulated upon c/N-myc deletion, we classified
each gene based on its relative expression pattern in the
different conditions with respect to its mean expression level
across conditions (Figure S2D). Consistent with a function of
Myc as both a transcriptional activator and repressor (Adhikary
and Eilers, 2005; Walz et al., 2014), we found 215 genes signifi-
cantly downregulated (clusters 44 + 48 + 60) and 165 genes up-
regulated (clusters 5 + 17 + 21) in dKO ESCs (false discovery rate
[FDR] = 0.1; Table S2). Genes downregulated upon loss of Myc
were enriched in Gene Ontology (GO) categories related to
several metabolic and biosynthetic aspects of cellular physi-
ology (clusters 44 and 48) including biosynthesis (ribosome
biogenesis; e.g., Ipo4, Utp15), gene expression (e.g., Eif3a,
Gabp1), metabolism (RNA metabolic process; e.g., Polr1b,
Polr3g), nucleus (nuclear part; e.g., Ncl, Xpot), and proliferation
(DNA replication; e.g., Orc1, Rfc1) (Figure 2C). Translation fac-
tors, transcription initiation, andDNA replicationwere also down-
regulated in dKO compared to c-mycD/D; N-mycD/fl ESCs (Fig-
ure 2D). To functionally assess the reduction in protein
synthesis caused by loss of Myc activity, we made use of an
alkyne analog of puromycin, O-propargyl-puromycin (OP-Puro)
(Liu et al., 2012; Signer et al., 2014), that can diffuse through
the plasma membrane of living cells, enter the ribosome
acceptor sites and be incorporated into the C terminus of
nascent polypeptide chains. OP-Puro can be fluorescently
labeled with an azide-alkyne reaction, thereby allowing quantifi-
cation of de novo protein synthesis. By using this assay, we show
that OP-Puro incorporation is homogeneously decreased in dKO
ESCs 96 hr after Cre induction, confirming the dramatic reduc-
tion of protein translation observed in the molecular signature
(Figures 2E and S2E). Consistent with our cell-cycle analysis
(Figures 1F and 1H), we found 24 genes related to proliferation
to be differentially expressed indKOESCs (FDR=0.1; Figure 2F).
These include Pola1, the regulatory subunit of DNA polymerase,
E2f3, known to be critical for normal cellular proliferation (Hum-
bert et al., 2000) and Skp2, among others. Finally, processes
related to immune response (positive regulation of immune sys-
tem process; e.g., Cd74, Fcer1g), development (central nervous
system development; e.g., Hes1, Hoxb1) and motility (locomo-
tion; e.g., Klf7, Ndn) were over-represented among the genes
upregulated in the dKO ESCs (cluster 17; Figure 2G). In agree-
ment with previous studies in both HSCs and skin epidermis
(Gebhardt et al., 2006; Wilson et al., 2004), integrin-mediated(D) Violin representation of the distribution of log fold changes (base 2) of c-myc
pathways of the genes (as annotated by WikiPathways). Significantly downregu
cesses are represented in red (FDR = 0.1).
(E) Translation activity of ESCs cultured in 2i. Representative FACS plots showin
compared to c-mycfl/fl; N-mycfl/fl (gray) and c-mycD/D; N-mycD/fl (blue) ESCs.
(F) Heatmap representation of the relative fold changes (base 2), with respect to
associated to the cell cycle.
(G) Over-represented GO categories in the genes upregulated in dKO ESCs (at 9
672 Cell 164, 668–680, February 11, 2016 ª2016 The Authorssignaling processes were upregulated in dKO ESCs (Figure 2D).
Pathways associated with survival and maintenance of ESCs
such as IL-6 signaling (Nichols et al., 1994) were enriched in
Myc-deficient ESCs (Figure 2D). Together, these data indicate
that dKO ESCs display an increase in cell adhesion and pro-
cesses associated with maintenance and survival and enter a
state of biosynthetic quiescence, characterized by a strong
reduction of protein and nucleic acid synthesis.
The Dormant State Induced by Myc Depletion Is
Reversible
Maintenance of pluripotency in the absence of differentiation
raised the question whether the proliferative and biosynthetic
quiescence observed in the dKO ESCs represents a terminal
or a reversible status. To approach this, we transfected dKO
cells with synthetic c-mycmRNAs to transiently restore Myc ac-
tivity (Figure 3A) (Warren et al., 2010). Upon expression of exog-
enous c-myc mRNAs, dKO ESCs re-entered the cell cycle, as
shown by a significant increase in 5-bromo-20- deoxyuridine
(BrdU) incorporation (Figure 3B) and restoration of translational
activity (Figures 3C and S3A). These results indicate that upon
re-expression of c-myc by exogenous mRNAs, dKO ESCs tran-
siently exit the status of biosynthetic dormancy and restore pro-
tein biosynthesis and DNA replication. The dimerization of Myc
with Max, a helix-loop-helix leucine zipper protein, is necessary
for the binding ofMyc to the promoters of its target genes (Black-
wood and Eisenman, 1991; Eilers and Eisenman, 2008). Low-
molecular-weight compounds, such as 10058-F4, have been
shown to inhibit both c-Myc and N-Myc activity by selective tar-
geting of Myc-Max dimerization both in vitro and in vivo (Rahl
et al., 2010; Zirath et al., 2013). In order to evaluate the long-
term reversibility of the phenotype induced by Myc depletion,
we treated naive ground-state ESCs with the Myc inhibitor
10058-F4 (MYCi) for 60 hr and analyzed the effect on cell prolif-
eration, protein translation, and pluripotency. Entirely consistent
with our previous results on dKO cells, mouse ESCs cultured in
the presence of MYCi formed small, undifferentiated colonies
(Figure 3D), which showed drastically reduced DNA and pro-
tein synthesis (Figures 3E, 3F, S3B, and S3C) but retained the
expression of pluripotency factors such as Nanog and Oct4 (Fig-
ures 3G and S3D). Importantly, upon withdrawal of the inhibitor,
these ‘‘released’’ cells (MYCi / released) rapidly exited the
state of dormancy and reactivated both DNA and protein synthe-
sis (Figures 3E, 3F, S3B, and S3C).We next compared themicro-
array expression profiles of ESCs cultured for 60 hr with the
MYCi to the ones of control cells (control) or inhibitor-treated
ESCs, 48 hr after MYCi withdrawal (released). This analysis re-
vealed 3,570 differentially expressed genes (DEGs) between
MYCi ESCs and the control group (FDR = 0.05, log2 fold
change ± 0.5; Figure 3H; Table S3). Consistent with theGO termsD/D; N-mycD/fl ESCs with respect to the dKO ESCs stratified by the biological
lated pathways in dKO ESCs are depicted in blue, whereas upregulated pro-
g reduced OP-Puro incorporation in dKO ESCs 96 hr after Cre induction (red)
the mean expression across conditions of the differentially expressed genes
6 hr; cluster 17).
(legend on next page)
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enriched in the RNA sequencing (RNA-seq) analysis of the dKO
cells (Figures 2C and 2G), processes related to cellular growth
(e.g., mRNA processing; ribosome biogenesis), metabolism
(e.g., DNA metabolic process) and proliferation (e.g., cell cycle;
DNA replication) were strongly downregulated upon MYCi treat-
ment. In contrast, processes related to signaling (e.g., regulation
of signal transduction) and development (e.g., developmental
process) were consistently upregulated (Figure S3E). Impor-
tantly, the comparison of the MYCi-treated with the released
group showed rapid re-activation of all the biosynthetic and pro-
liferative activities: genes and GO terms related to mRNA pro-
cessing (e.g., Polr2d; Srpk1), RNA splicing (e.g., Syncript;
Srsf1), ribosome biogenesis (e.g., Ncl; Wdr12), DNA replication
(e.g., Cdc6; Dna2), and cell cycle (e.g., Ccnd1) were rapidly up-
regulated in the released group already 48 hr after withdrawal of
the inhibitor (Figures 3I and 3J). Interestingly, Cdk6, recently
shown to regulate exit from quiescence in human HSCs (Laurenti
et al., 2015), was also rapidly induced upon exit from the Myc-
induced dormant state in mouse ESCs (Figure 3J). Despite the
transient depletion of Myc activity, ESCs retained their functional
pluripotency and upon exit from the state of dormancy,
MYCi-released ESCs were capable of both in vitro and in vivo
differentiation toward the three germ layers (Figures 3K and
3L). In summary, our data indicate that treatment of ESCs
with MYCi not only recapitulates the dKO phenotype at the
molecular and functional level, but also demonstrates that the
status of biosynthetic dormancy induced by transient loss of
Myc activity in naive ground-state ESCs is reversible and occurs
without compromising their stem cell identity and pluripotent
potential.
Comparison of Expression Signatures between
Myc-Depleted ESCs and the Diapause Epiblast
In numerous invertebrates and almost 100 mammalian species,
embryonic development can be reversibly arrested as a strategy
to enhance the reproductive fitness in response to changes in
the living environment (Renfree and Shaw, 2000). In breast-
feeding mice, delayed implantation, termed diapause, can occurFigure 3. The Dormant State Induced by Myc Depletion Is Reversible
(A–C) Expression of exogenous c-myc mRNAs transiently rescues the dKO phen
(A) Experimental workflow. c-mycD/D; N-mycD/fl ESCswere transfected with an EF
N-mycD/fl) and positive (dKO) cells. Sorted cells were plated in 2i medium and 72
Control samples were treated with Lipofectamine only. Sample analysis was per
(B) Quantitative analysis of BrdU incorporation measured by flow cytometry. The
(C) Representative FACS plots of OP-Puro incorporation in dKO ESCs and dKO
(D–L) Treatment of ESCs with the Myc inhibitor 10058-F4 (MYCi) recapitulates th
of biosynthetic dormancy induced by depletion of Myc activity. Mouse ESCs wer
released group was treated with MYCi for 60 hr, followed by withdrawal of the in
(D) Phase-contrast microscopy images. Scale bar, 100 mm.
(E) Representative flow cytometry plots of the cell-cycle profiles based on the m
(F) FACS analysis of OP-Puro incorporation to measure ESCs translational activi
(G) Representative fluorescence staining for Nanog. Scale bar, 50 mm.
(H–J) Microarray expression analysis of mouse ESCs treated with MYCi.
(H) Venn diagram showing the number of differentially expressed genes (DEG) (lo
(I) Clustered heatmaps of DEG in the indicated GO terms.
(J) Expression levels of representative DEG in the selected GO categories.
(K and L) MYCi-treated ESCs retain pluripotency.
(K) Fluorescence staining of in-vitro-differentiated ESCs for Tuj1, Sma, and Gata
(L) Hematoxylin and eosin staining of teratomas derived from ESCs treated with
674 Cell 164, 668–680, February 11, 2016 ª2016 The Authorsin response to decreased levels of estrogen, which cause blas-
tocysts to enter a transient dormant state of metabolic and pro-
liferative quiescence (Hondo and Stewart, 2005; Mantalenakis
and Ketchel, 1966). Our observation that the combined loss of
c-myc and N-myc in ground-state ESCs induces biosynthetic
dormancy raised the possibility that dKO ESCs may resemble
a state equivalent to mammalian epiblast cells in diapause. To
test this hypothesis, we experimentally induced delayed implan-
tation by ovariectomizing E2.5 pregnant females and isolated di-
apaused embryos 4 days later. Additionally, we made use of
recently generated transcriptome profiling data (RNA-seq) of di-
apaused and E4.5 pre-implantation epiblasts (Table S4) (Boro-
viak et al., 2015). As expected, diapaused embryos retained an
active pluripotency network, as shown by the expression of
Nanog, Oct4, and Zfp42 (Figures 4A–4C) (Batlle-Morera et al.,
2008; Silva et al., 2009). Remarkably, the expression of c-Myc
proteins and transcripts was low to undetectable during
diapause (Figures 4D, 4E, S4A, and S4B), and Myc downregula-
tion was associated with a significant decrease of Ki67 expres-
sion (Figures S4C and S4D) and reduced incorporation of both
EdU (5-Ethynyl-20-deoxyuridine) and OP-Puro (Figures 4F, 4G,
S4E, and S4F). This reduction in DNA and protein synthesis func-
tionally describes the state of biosynthetic and proliferative
quiescence of diapaused embryos and remarkably resembles
the functional phenotype of dKO ESCs. To evaluate the similarity
of dKO ESCs to the diapause epiblast, we compared the molec-
ular expression signatures of dKO cells to those of normal pre-
implantation and diapaused epiblasts (Table S4) (Boroviak
et al., 2015). Performing 2D GO enrichment analysis of RNA
expression changes (comparing control ESCs/dKO ESCs and
E4.5 normal/diapause epiblasts; Figure 5A), we found that genes
from specific biological processes showed a strong positive cor-
relation between both datasets. Specifically, processes related
to gene expression (e.g., RNA processing, RNA splicing, RNA
export from nucleus), protein synthesis (e.g., ribosome biogen-
esis, translation), and proliferation (e.g., DNA replication, replica-
tion fork, chromosome segregation) were robustly downregu-
lated in both datasets (Figures 5B–5D and S5A–S5C). Inotype.
1a-mCherry-Cre plasmid and sorted 24 hr later asmCherry negative (c-mycD/D;
hr after sort were transfected twice with c-mycmRNAs (dKO/c-mycmRNA).
formed 8 hr after the second mRNA transfection.
bar charts indicate the mean ± SEM; n = 3.
cells transfected with c-myc mRNAs (dKO/ c-myc mRNA).
e dKO phenotype and shows molecular and functional reversibility of the state
e analyzed after 60 hr of treatment with DMSO (Control) or MYCi. The MYCi/
hibitor and culture in 2i medium for additional 48 hr.
easurement of BrdU incorporation and total DNA content (7AAD).
ty.
g2 fc > ± 0.5; FDR = 0.05) between the different conditions and their overlaps.
6. Scale bar, 100 mm.
MYCi for 60 hr prior injection into immune-deficient mice. Scale bar, 50 mm.
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Figure 4. Translation, Proliferation, and
Myc Expression Are Reduced in Diapause
Embryos
(A–C) Expression of pluripotency markers in the
diapaused embryos. Confocal microscope images
of peri-implantation (E3.5) and diapause embryos
immunostained for Nanog (A) or Oct4 (B). Scale bar,
20 mm. (C) RNA-seq data based on Boroviak et al.
(2015) showing expression levels of Nanog and
Zfp42 in E4.5 and diapause embryos. Bar graphs
show FPKM (fragments per kilobase of exon per
million reads mapped) values and are represented
as mean ± SEM. E4.5 epiblast (n = 3); diapause
epiblast (n = 2).
(D and E) Diapause embryos have reduced Myc
expression.
(D) Fluorescence staining for c-Myc in E4.5 and
diapause embryos. Scale bar, 20 mm. Images are
representative of two independent experiments.
(E) Expression levels of c-myc and N-myc in the
epiblast of pre-implantation (E4.5) and diapause
embryos. RNA-seq data based on Boroviak et al.
(2015). E4.5 epiblast (n = 3); diapause epiblast
(n = 2). Values are represented as mean ± SEM.
(F and G) Diapause embryos are characterized by
reduced DNA and protein synthesis. Representa-
tive confocal microscope images showing EdU (F)
andOP-Puro (G) incorporation in E4.5 and diapause
embryos. Scale bar, 20 mm.contrast, processes related to cell adhesion (e.g., Integrin bind-
ing) and signaling (e.g., signaling receptor activity, G protein
coupled receptor activity) were commonly upregulated (Figures
5E, S5D, and S5E). These expression profiling data strongly indi-
cate that the transcriptomic changes occurring uponMyc deple-
tion in naive ground-state ESCs closely correlate with the ones
observed during induction of diapause.
Inhibition ofMycActivity inMouseBlastocysts Induces a
Diapause-like State of Dormancy
To investigate whether reduction of Myc activity can induce
a diapause-like state in normal, pre-implantation embryos, we
isolated E3.75–E4.0 blastocysts and cultured them in the pres-
ence of the MYCi for 18 hr. This resulted in a striking reduction
of both de novo protein synthesis (Figures 6A and 6B) and
cellular proliferation (Figure 6C). Importantly, pluripotency
markers such as Oct4 were still expressed upon Myc inhibition
(Figure 6D), highlighting the maintenance of the stem cell cir-
cuitry in the epiblast of Myc-inhibited embryos. Next, we as-
sessed the ability of those Myc-inhibited, diapause-like blasto-
cysts to resume development upon withdrawal of MYCi by
transferring MYCi-treated embryos into the uterus of pseudo-
pregnant foster mothers. MYCi-treated blastocysts yielded
morphologically normal embryos at E15.5 and live born pups
(Figures 6E and 6F). These findings not only show that Myc is
downregulated in diapause embryos, but also demonstratethat transient reduction of Myc activity is sufficient to drive em-
bryos into a reversible diapause-like state, functionally charac-
terized by strong reduction of proliferation and protein synthe-
sis while a fully functional pluripotent developmental program is
maintained.
DISCUSSION
The stem cell self-renewal comprises two biological processes,
namely, cellular growth-proliferation linked to inhibition of differ-
entiation. The latter is synonymous with the capacity to maintain
stem cell pluripotency or multipotency in at least one of the
daughter cells after cell division. By using both a genetic model
and an inhibitor of Myc activity, our data demonstrate that, while
Myc controls biosynthetic activity and cellular proliferation of
naive ground-state ESCs, the maintenance of pluripotency and
stem cell identity is independent of Myc. In the absence of
Myc activity, maintenance of pluripotency and the associated
lack of differentiation are only observed in 2i-cultured ground-
state ESCs and in the blastocyst. These findings suggest that
the effects of Myc are highly linked to the microenvironmental
signals naturally present in the uterus and recapitulated in vitro
by the 2i culture. Thus, the two key components of ESC self-
renewal can be separated into a Myc-controlled biosynthetic
program and a Myc-independent pluripotency program. These
results strongly support findings in other cell types, includingCell 164, 668–680, February 11, 2016 ª2016 The Authors 675
Figure 5. Correlation of Expression Signa-
tures between Myc-Depleted ESCs and
Diapause Epiblasts
(A) 2D GO enrichment analysis of RNA expression
changes of dKO/c-mycfl/fl; N-mycfl/fl (WT) ESCs
and Diapause/E4.5 epiblasts. Dataset is from
Boroviak et al. (2015). Red regions correspond to
concordantly higher or lower expression. Blue and
green regions correspond to lower or higher
expression in one direction, but not in the other.
Terms in yellow regions show anti-correlating
behavior. Analysis was performed using the
Perseus software according to Cox and Mann
(2008). FDR = 0.02.
(B–E) Scatterplots of pathways significantly
changed both in the comparison dKO/WT (FDR =
0.1) and in Diapause/E4.5 (FDR = 0.1). The gray
dots represent the set of all genes. Genes
belonging to the specific pathways are highlighted
in blue (downregulated processes) or red (upre-
gulated processes). The x axis shows the DESeq2-
moderated log2 fold change (log2 fc) between the
diapause compared to the E4.5 epiblast; the y axis
shows the DESeq2-moderated log2 fc between the
dKO ESCs compared to c-mycfl/fl; N-mycfl/fl (WT)
cells. The violin plots at the margins show the
marginal distributions of fold changes of the genes
in the highlighted pathways.cancer cells (Carroll et al., 2015; Dang, 2013, 2015), and are in
agreement with a recently described Myc-centered transcrip-
tional module (Kim et al., 2010). Diapause is a unique biological
phenomenon, developed in many invertebrates (e.g., butterflies,
C. elegans) and mammals (e.g., rodents, deer) as a reproductive
strategy to survive predictable, unfavorable environmental con-
ditions, such as temperature extremes, drought, or reduced
food availability (Renfree and Shaw, 2000). In the mouse, hor-
monally mediated diapause of pre-implantation embryos occurs
if the mother still nurses pups of the previous litter (Hondo
and Stewart, 2005; Mantalenakis and Ketchel, 1966). During
diapause, embryos or organisms undergo a reversible biosyn-
thetic/metabolic dormancy, in which certain cells must retain
their properties of pluri-/multipotency to ensure reactivation of
development at later stages. The molecular mechanisms gov-
erning mouse embryonic diapause are largely unsolved and
key factors regulating embryonic dormancy have yet to be iden-
tified (Hondo andStewart, 2005). In this study, we identifyMyc as
a master regulator of RNA processing, protein synthesis, and
proliferation both in 2i-cultured ESCs and in the pre-implantation676 Cell 164, 668–680, February 11, 2016 ª2016 The Authorsembryo and propose the depletion of Myc
activity as an important signal for the
execution of the diapause program. Myc
expression is indeed strongly reduced
during the physiological and reversible
state of embryonic dormancy, and cellular
processes controlled by Myc in ESCs,
such as RNA splicing, DNA and protein
synthesis, and cellular proliferation, are
dramatically affected during diapause.The observation that transient inhibition ofMyc activity in pre-im-
plantation blastocysts is on its own sufficient to trigger a
diapause-like state of biosynthetic suspension without affecting
pluripotent identity or compromising the developmental program
is remarkable. Upon release of Myc inhibition, ground-state ESC
re-enter into the cell cycle and diapause-like embryos progress
through their normal developmental program. Yet, finely tunable
genetic gain-of-function models will be needed to assess
whether sustained Myc expression would prevent entry into
diapause and provide additional evidence that Myc activity is
sufficient to exit from the dormant state in vivo. Biosynthetic
and energetic demands are intimately coupled. Diapaused em-
bryos are characterized by a robust downregulation of biosyn-
thetic processes, which is likely associated with a reduced
bioenergetic activity. Metabolomics studies will need to explore
whether the type or only the extent of energy production is
different in normal and diapause embryos and how Myc inter-
feres with this process (Hsieh et al., 2015; Takubo et al., 2013).
In summary, our findings suggest pluripotent stem cell dormancy
as a Myclow state and identify differential Myc activity as a key
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Figure 6. Inhibition of Myc Activity Induces a Diapause-like State in Mouse Blastocysts
E3.75–E4.0 embryos were collected from pregnant females and treated for 18 hr with MYCi or DMSO (Control).
(A) Representative confocal microscope images of OP-Puro incorporation. Scale bar, 20 mm.
(B) Quantification of (A). Values are represented as mean ± SEM. MYCi (n = 6); Control (n = 7).
(C) Representative images of EdU incorporation. Scale bar, 20 mm.
(D) Confocal microscopy images of embryos immunostained for Oct4. Scale bar, 20 mm.
(E and F) MYCi-treated and control blastocysts were transplanted into the uteri of pseudo-pregnant foster mothers.
(E) Representative images of E15.5 embryos derived from MYCi-treated or control blastocysts. This result is representative of two independent experiments.
MYCi (n = 24 embryos E15.5); control (n = 11 embryos E15.5). Scale bar, 0.5 cm.
(F) Representative picture of the litter generated from the transplant of MYCi-treated blastocysts into pseudo-pregnant foster mothers. The result is repre-
sentative of two independent experiments. In the MYCi condition, totally nine litters were born from nine embryo-transferred foster mothers (totally 64 live-born
mice).event in orchestrating the complex and rapid changes occurring
during entry and exit from diapause.
Successful implantation results from the reciprocal interaction
between an implantation-competent blastocyst and the recep-
tive uterus (Wang and Dey, 2006). Among other factors, the es-
trogen-induced cytokine LIF, secreted first by the uterine glands
and then by the surrounding stroma, is crucial for the preparation
of the uterus for implantation. Females lacking a functional LIF
gene are fertile, but their blastocysts fail to implant and can
only continue embryogenesis if transferred to wild-type
pseudo-pregnant recipients (Chen et al., 2000; Stewart et al.,
1992). Similarly, embryos lacking gp130, part of the LIF receptor
complex, cannot resume development after undergoing
diapause (Nichols et al., 2001), confirming the essential role of
LIF/Stat3 signaling within the diapause program. Although it
has been suggested that c-Myc lies downstream of LIF/Stat3in ESCs cultured in serum (Cartwright et al., 2005), the connec-
tion between the two pathways remains controversial in ESCs
and may depend on culture conditions (Hall et al., 2009; Martello
et al., 2013). To identify the mechanisms controlling Myc activity
in normal and diapaused epiblasts within their natural uterine
microenvironment, future studies will need to elucidate the com-
plex signaling interactions between LIF/Stat3 and Myc down-
stream of estrogens.
At the cellular level, our findings may not be restricted to the
embryo but also apply to dormant, somatic stem cells where
the quiescent state is known to protect them from mutations
that might occur following replicative stress and result in aging,
stem cell loss, or in the transition toward a cancerous state
(Cheung and Rando, 2013; Latil et al., 2012; Sosa et al., 2014;
Wagner et al., 1993; Wilson et al., 2008, 2009). In the
hematopoietic system, for instance, the exit of HSCs fromCell 164, 668–680, February 11, 2016 ª2016 The Authors 677
dormancy triggered by interferon-a is associated to the upregu-
lation of c-Myc protein (Ehninger et al., 2014). Additionally, upon
conditional deletion of both c-myc and N-myc in the bone
marrow, the only maintained blood cells are dormant HSCs,
while non-stem cells undergo rapid apoptosis (Laurenti et al.,
2008, 2009). Dormancy is therefore a transient stem cell state,
molecularly defined by extremely low levels of Myc expression,
where the most primitive cells within the stem cell compartment
can be stored as a transiently quiescent reservoir to preserve
genomic integrity and be protected from microenvironmental
hazards (Baldridge et al., 2010; Essers et al., 2009; Flach et al.,
2014; Walter et al., 2015; Wilson et al., 2008). This phenomenon
might not be exclusive to normal stem cells but similarly be ex-
ploited in cancer, for example, by malignant metastatic stem
cells following invasion into a new tissue environment (Oskars-
son et al., 2014; Sosa et al., 2014). In tumor cells with stem-
like character, environmentally mediated physiological downre-
gulation or pharmacological inhibition of Myc may thus induce
tumor cell dormancy instead of apoptosis.
EXPERIMENTAL PROCEDURES
Other procedures and reagents details are provided in the Supplemental
Experimental Procedures.
Mice
Six- to 12-week-oldmice were used throughout the study. C57BL/6mice were
purchased from Harlan Laboratories. Teratoma assays were performed in
NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice. c-mycfl/fl; N-mycfl/fl;
RosaEYFPfl/fl (Knoepfler et al., 2002; Srinivas et al., 2001; Trumpp et al.,
2001) and c-MyceGFP/eGFP (Huang et al., 2008) mice were bred in-house in
the animal facility of the DKFZ, Heidelberg, Germany. All miceweremaintained
at the DKFZ under specific pathogen-free (SPF) conditions in individually venti-
lated cages (IVCs). Animal procedures were performed according to protocols
approved by the German authorities, Regierungspra¨sidium Karlsruhe (Nr.
Z110/02, DKFZ 299 and G135/15).
Embryonic Stem Cell Derivation and Culture
Mouse ESCs were derived from 8- to 10-week-old c-mycfl/fl; N-mycfl/fl;
RosaEYFPfl/fl (Knoepfler et al., 2002; Srinivas et al., 2001; Trumpp et al.,
2001) or c-MyceGFP/eGFP (Huang et al., 2008) mice. Females were injected
intraperitoneally with 7U of pregnant mare serum gonadotropin (PMSG) fol-
lowed by 7 U of human chorionic gonadotropin (hCG), injected 47 hr later. Fe-
males were then paired with males and checked for vaginal plug the following
morning, considered as 0.5 days post-coitum (dpc). 2.5-dpc embryos were
flushed from the oviducts into a plastic dish with M2 medium (Sigma,
M7167). Embryos were washed ten times in M2 medium. To remove the
zona pellucida, embryos were incubated shortly in Tyrode’s solution (Sigma,
T1788-100ML) and transferred again to M2 medium. Finally, each embryo
was cultured on a layer of mitotically inactivated mouse embryonic fibroblasts
(MEFs). ESCs were routinely propagated on 0.1% gelatin-coated plates,
without feeders or serum, in N2B27 medium (NDiff N2B27 base medium,
Stem Cell Sciences, SCS-SF-NB-02) supplemented with the small-molecule
inhibitors PD0325901 (Stemgent, 04-0006, 1 mM) and CHIR99021 (Stemgent,
04-0004, 3 mM), LIF (Millipore, ESG1106, 1,000 U/ml), and b-mercaptoethanol
(Gibco, 31350-010, 0.05 mM). Cells were replated every 3 days following
dissociation with StemPro Accutase (Gibco, A11105-01). In the experiments
with serum, ESCs were cultured on MEFs in knockout DMEM medium
(Gibco, 10829) supplemented with L-glutamine (Gibco, 25030-081, 2 mM),
LIF (Millipore, ESG1106, 1,000 U/ml), b-mercaptoethanol (Gibco, 31350-010,
0.05 mM), and 15% ESC-tested FBS (Pansera ES, Pan Biotech, 2602-
P271303). In the experiments with the small-molecule inhibitor 10058-F4
(MYCi) (Calbiochem, 475956), MYCi was dissolved in 2i medium at a final con-678 Cell 164, 668–680, February 11, 2016 ª2016 The Authorscentration of 64 mM. As a control, DMSO alone was added at the same final
volume as MYCi.
Induction of Diapause
Six- to 10-week-old female mice were injected intraperitoneally with 7 U of
pregnant mare serum gonadotropin (PMSG) followed by 7 U of human chori-
onic gonadotropin (hCG), injected 48 hr later. The females were paired with
males and checked for vaginal plug the following morning, considered as
0.5 days postcoitum (dpc). At 2.5 dpc, the females were ovariectomized,
and diapause embryos were isolated by uterine flush 4 days later at 6.5 dpc.
The control group was not operated and females were sacrificed at 3.5 or
4.5 dpc for embryo isolation.
Treatment of Mouse Blastocysts with the Myc Inhibitor 10058-F4
and Embryo Transfer
E3.75–E4.0 embryoswere collected from superovulatedC57BL/6 pregnant fe-
males and incubated for 18 hr with the Myc inhibitor (MYCi) 10058-F4 (Calbio-
chem, 475956, final concentration 55 mM) in EmbryoMax KSOM medium +
amino acids (Merck Millipore, MR121-D). The control group was treated with
DMSO alone, added at the same final volume as the inhibitor. Treated embryos
were transferred into the uterus of CD1 pseudo-pregnant foster mothers and
analyzed at E15.5 or after birth.
Analysis of OP-Puro and EdU Incorporation Using the Click-iT
Technology
To measure protein synthesis, in-vitro-cultured ESCs or mouse embryos were
incubated for 1 hr in 2i medium or EmbryoMax KSOM medium + amino acids
(Merck Millipore, MR121-D), respectively, supplemented with O-propargyl-
puromycin (OP-Puro) (Jena Biosciences, NU-931-05, 50 mM final concentra-
tion). After harvesting, the samples were fixed for 15 min at room temperature
in PBS supplemented with 4% paraformaldehyde (Electron Microscopy Sci-
ences, 19208) and then permeabilized in PBS supplemented with 1% BSA
and 0.1% saponin for 5 min at room temperature. The copper-catalyzed
azide-alkyne cycloaddition (CuAAC) was performed using an Alexa 647-azide
(Life Technologies, A10277, 5 mM final concentration) and the Click-iT Cell Re-
action Buffer Kit (Life Technologies, C10269) according to the manufacturer’s
instructions. For the analysis of EdU incorporation, isolated embryos were
incubated in EmbryoMax KSOM medium + amino acids (Merck Millipore,
MR121-D) supplemented with EdU (10 mM final concentration) for 80 min.
EdU labeling and staining of the embryos were performed using the Click-iT
Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit (Life Technologies,
C10634) according to the manufacturer’s instructions.
Statistical Analysis
Data were processed using Prism 6 (GraphPad Software). All analyses
were performed using two-tailed Student’s t tests (unless otherwise specified).
Statistical significance is indicated by *p < 0.05; **p < 0.01; ***p < 0.001; and
****p < 0.0001.
ACCESSION NUMBERS
The accession number for the RNA-seq data reported in this paper is
ArrayExpress: E-MTAB-3386. The accession number for the microarray data
is GEO: GSE74337.
SUPPLEMENTAL INFORMATION
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five figures, four tables, and one data file and can be found with this article
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Figure S1. Myc Is Required for Proliferation but Not for Maintenance of the Core Pluripotency Network in 2i ESCs, Related to Figure 1
(A and B) c-mycfl/fl; N-mycfl/fl ESC lines are capable of multilineage differentiation.
(A) Fluorescence staining of in vitro differentiated ESCs for Tuj1, Sma and Gata6. Scale bar, 100 mm.
(B) Haematoxylin and eosin staining of teratomas derived from c-mycfl/fl; N-mycfl/fl ESCs. Representative images reveal structures derived from all the three germ
layers. Scale bars, 50 mm (ectoderm and mesoderm) and 20 mm (endoderm).
(C) Experimental workflow. c-mycfl/fl; N-mycfl/fl Rosa26lox-stop-loxEYFP ESC were transduced with an EF1a-Cre plasmid and Cre positive (EYFP+) cells were FACS
sorted and cultured in 2i, propagated as single clones and genotyped.
(D) PCR analysis of representative ESC clones for the c-mycflox, c-mycD, N-mycflox and N-mycD alleles.
(E) Number of clones obtained for each genotype.
(F and G) Lack of either c-myc or N-myc does not affect ESCs multilineage differentiation potential.
(F) Fluorescence staining for Tuj1, Sma and Gata6 of c-mycD/D; N-mycD//fl and c-mycD/fl; N-mycDlD ESCs differentiated in vitro. Scale bar, 100 mm.
(G) Representative images of hematoxylin and eosin staining of teratomas from mycD/D; N-mycD//fl and c-mycD/fl; N-mycDlD ESCs. Scale bar, 50 mm.
(H and I) c-mycD/D; N-mycD//fl ESCswere transfected with an EF1a-mCherry-Cre plasmid andmCherry positive (Cre+) and negative (Cre-) cells were FACS sorted
and cultured in 2i. Not transfected (NT) cells were used as controls.
(H) PCR of the c-mycflox, c-mycD, N-mycflox and N-mycD alleles was performed 24h after transfection.
(I) qRT-PCR analysis for c-myc and N-mycwas performed 24h and 96h after transfection. Transcript levels of c-myc and N-mycwere normalized toGapdh. Data
are presented as the mean ± SEM of duplicate wells from a representative experiment.
(J) Lack of either c-myc or N-myc does not affect the proliferation of ESCs cultured in 2i. Cell cycle analysis of ESCs in the G0, G1 and S/G2/M phases as
determined by Hoechst versus intracellular Ki67 staining. Bar graphs indicate the mean ± SD of two replicates, representative of two independent experiments.
(K) Representative flow cytometry plots of ESCs stained for cleaved Caspase 3. ESCs incubated for 10 min at 42C were used as positive control.
(L) Representative images of c-mycD/fl; N-mycDlD ESCs stained for Nanog or Oct4. Scale bar, 50 mm.
(M) FACS analysis of Sox2 expression in c-mycfl/fl; N-mycfllfl, c-mycD/D; N-mycD//fl and dKO ESCs.
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Figure S2. Loss of Myc Activity Induces Cellular Dormancy in ESCs Cultured in 2i, Related to Figure 2
(A) RNA-seq workflow. Total RNA starting material was 10 ng. 100 bp paired–end libraries of two biological replicates for each condition were sequenced. We
obtained 1x108 sequenced fragments per sample and detected the expression of more than 28,000 genes.
(B) Number of sequenced fragments of the genes c-myc and N-myc on each sample.
(C) RNA-seq expression levels of Rex1 (Zpf42) in dKO ESCs compared to the controls. Bar graphs are represented as mean ± SD.
(D) Gene expression clusters. For each of the genes detected to be differentially expressed, we estimated the relative fold change between each condition with
respect to themean expression across all the six conditions. The geneswere grouped based on the signs of the relative fold change on each of the 64 (26) possible
combinations. For instance, all the genes that showed a positive sign for the c-mycfl/fl; N-mycfl/fl and a negative sign for the rest of the conditions were grouped
together.
(E) Quantification of OP-Puro incorporation in c-mycfl/fl; N-mycfl/fl, c-mycD/D; N-mycDlfl and dKO ESCs. Values represent geometrical mean (Geo Mean) ± SEM.
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Figure S3. The Dormant State Induced by Myc Depletion Is Reversible, Related to Figure 3
(A) Representative FACS plots of OP-Puro incorporation in c-mycfl/fl; N-mycfl/fl (black), c-mycD/D; N-mycD/fl (blue), dKO (red) ESCs and dKO cells transfected with
c-myc mRNAs (green). Experimental setting as described in Figure 3A.
(B–E) Mouse ESCs were analyzed after 60h of treatment with DMSO (Control) or MYCi. The MYCi/Released group was treated with MYCi for 60h, followed by
withdrawal of the inhibitor and culture in 2i medium for additional 48h. (B) Quantitative analysis of the different cell cycle phases as gated in Figure 3E. The bar
charts indicate the mean ± SD (C) Quantification of OP-Puro incorporation in the indicated experimental groups. Values represent geometrical mean (Geo
Mean) ± SD. (D) Representative fluorescence staining for Oct4. Scale bar, 50 mm. (E) Microarray analysis of mouse ESCs treated with MYCi. List of selected
processes down- or upregulated in the MYCi-treated group compared to the control (FDR 0.05).
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Figure S4. Translation, Proliferation, and Myc Expression Are Reduced in Diapause Embryos, Related to Figure 4
(A) c-Myc protein expression in E4.5 and diapause embryos. Quantification of confocal microscopy images as in Figure 4D.
(B) Expression levels of l-myc in the epiblast of E4.5 and diapause embryos. RNA-seq data based on (Boroviak et al., 2015). Bar graphs show FPKM values and
are represented as mean ± SEM. E4.5 epiblast (n = 3); diapause epiblast (n = 2).
(C) Fluorescence staining for Ki67 (red) and DAPI (blue) in E4.5 and diapause embryos. Scale bar, 20 mm.
(D) Quantification of (C). Values are represented as mean ± SD.
(E) EdU incorporation in E4.5 and Diapause embryos. Quantification of confocal microscopy images as in Figure 4F.
(F) OP-Puro incorporation in E4.5 and Diapause embryos. Quantification of Figure 4G.
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Figure S5. Correlation of Expression Signatures between Myc Depleted ESCs and Diapause Epiblasts, Related to Figure 5
(A) Selected processes commonly downregulated in diapause embryos and dKO ESCs compared to E4.5 epiblast and c-mycfl/fl; N-mycfl/fl (WT) ESCs
respectively (FDR 0.1).
(B and C) Scatterplots of pathways significantly downregulated both in the comparison dKO / WT (FDR 0.1) and in Diapause / E4.5 (FDR 0.1).
(D) Selected processes commonly upregulated in diapause embryos and dKO ESCs compared to E4.5 epiblast and WT ESCs respectively (FDR 0.1).
(E) Scatterplots of pathways significantly upregulated both in the comparison dKO / WT (FDR 0.1) and in Diapause / E4.5 (FDR 0.1).
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  SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Conditional Deletion of c-myc and N-myc. Deletion of the floxed alleles in c-mycfl/fl; N-mycfl/fl; 
RosaEYFPfl/fl cells was induced by transient transfection of ESCs with the EF1α-CRE plasmid using 
Lipofectamine 2000 (Invitrogen, 1639722) according to the manufacturer’s instructions. Subsequent 
deletion of the remaining floxed allele was induced by transient transfection with an EF1α-mCherry-
CRE plasmid. mCherry-positive and negative cells were sorted by flow cytometry 24h after 
transfection. To confirm the deletion, genomic DNA was isolated from sorted or cultured cells using 
the DNeasy Blood and Tissue kit (Qiagen, 69506) according to the manufacturer’s instructions. 
 
Synthetic c-myc mRNA Production and Transfection. Synthetic modified mRNA was generated as 
previously described (Warren et al., 2010) with modifications as follows. RNA was synthesized using 
the AmpliscribeT7-Flash Transcription kit (Epicentre, Illumina company, Madison, WI) and the 
capping analogon was directly synthesized using the ScriptCap m7G Capping System and ScriptCap 
2’-O-Methytransferase Kit (Cellscript, Madison, WI). mRNA transfection was performed using 
Lipofectamine 2000 (Invitrogen, 1639722) according to manufacturer’s instructions and in culture 
medium not supplemented with PD0325901 (1i) since it negatively regulates c-Myc protein stability by 
inhibition of Erk signalling (Sears, 2004). ESCs were transfected with 2 µg/ml of synthetic c-myc 
mRNA or Lipofectamine only. A second mRNA transfection was performed 18h after the first as 
described above. The cells were analysed after additional 8h. 
 
In vitro Differentiation. ESCs were cultured in 2i on gelatine-coated dishes. For embryoid body (EB) 
formation ESCs were first harvested by digestion with StemPro® Accutase® for 5 min and dissociated 
until a single-cell suspension was achieved. The cell suspension was pelleted by centrifugation and 
resuspended in EB-Medium (DMEM, 15% FCS, 50 µM β-mercaptoethanol, NEAA) at a density of 5.5 
x 105 cells/ml. The forming EBs were cultured in suspension for 5 days and plated on gelatine-coated 
tissue dishes thereafter. Adherent cells were further differentiated for 5 days in EB-Medium. To 
address the pluripotent differentiation potential, cultures were fixed in 4% PFA and stained with 
antibodies against β-3-tubulin (Tuj1) (Covance, Princeton, NJ, MMS-435P, 1:1000), α-smooth muscle 
actin (Sma) (Sigma-Aldrich, A2547, 1:500) and Gata6 (R&B Systems, AF1700, 1:100). 
 
Flow Cytometry. Cell cycle analysis and cleaved Caspase 3 staining were performed by fixation and 
permeabilization with Cytofix/Cytoperm (Beckton Dickinson, 51-2090KZ). Intracellular staining with 
Ki67-Alexa647 antibody (BD biosciences, 558615) or cleaved Caspase 3-PE (BD Pharmigen, 51-
68655X) was done over night at 4°C in PermWash solution (Beckton Dickinson, 51-2091KZ). For cell 
cycle analysis, samples were then incubated with Hoechst33342 (Sigma, H3570) in PermWash solution 
for 10 min. For FACS analysis of BrdU incorporation combined with 7-AAD staining, ESCs were 
chased with BrdU (10 µM final concentration) for 15 min prior fixation. BrdU labelling and staining 
were performed using the APC BrdU Flow Kit (BD Pharmingen™, 552598) according to the 
manufacturer’s instructions. FACS analysis for Sox2 was performed using the BDTM Mouse 
Pluripotent Stem Cell Transcription Factor Analysis Kit (Becton Dickinson, 560585) according to the 
	  manufacturer’s instructions. FACS analysis was performed on LSRII or LSR Fortessa flow cytometers  
(Becton Dickinson, San Jose, CA). Data were analysed using the FlowJo software (Tree Star, Ashland, 
OR). Cell sorting experiments were carried out on a BD FACSAria™ III sorter (Becton Dickinson, San 
Jose, CA).  
 
Alkaline Phosphatase Staining. Alkaline Phosphatase staining was performed using the Stemgent® 
Alkaline Phosphatase Staining Kit II (Stemgent, 00-0055) according to the manufacturer’s instructions. 
 
Immunofluorescence Staining of ESCs. Cells were fixed for 15 min at room temperature in PBS 
supplemented with 4% paraformaldehyde (Electron Microscopy Sciences, 19208) and permeabilized in 
PBS containing 0.5% Triton X-100 for 10 min. The cells were then washed three times with 0.1% 
Tween 20 in PBS for 5 min at RT and blocked for 1h in PBS supplemented with 0.5 % BSA, 10% goat 
serum, 0.1% Triton X-100 in PBS. Antibody staining was carried out using the following antibodies, 
diluted in blocking solution: Nanog (Abcam, ab80892, 1:500); Oct4 (Abcam, ab19857, 1:500). After 
washing twice in PBS, the cells were incubated for 4h at RT with the secondary antibody donkey anti-
rabbit-Alexa Fluor 647 (Invitrogen, A-31573) diluted 1:300 in blocking solution. Following DAPI 
staining (Sigma, D9542), the slides were mounted with Faramount (Dako, S3035) and analysed on a 
Zeiss Cell Observer fluorescence microscope (Carl Zeiss, Jena, Germany).  
 
Immunofluorescence Staining of Embryos. Mouse embryos were fixed for 15 min at room 
temperature in PBS supplemented with 4% paraformaldehyde (Electron Microscopy Sciences, 19208) 
and washed in PBS. Embryos were then incubated with anti-Ki67-eFluor® 660 (eBioscience, 50-5698-
80, 1:500), anti-Nanog (Abcam, ab80892, 1:500) or anti-c-Myc (Santa Cruz Biotechnology, sc-764, 
1:500) diluted in PBS supplemented with 0.1% Triton X-100 and 1% BSA (PBS-T) overnight at 4°C. 
After washing with PBS-T, embryos were further incubated with the secondary antibody Alexa Fluor 
488 goat anti-rabbit (Jackson ImmunoResearch Laboratories, 111-545-003) or donkey anti-rabbit 
Alexa Fluor 647 (Invitrogen, A-31573) in PBS-T for 2h at room temperature. Embryos were washed in 
PBS-T and mounted in DAPI-mounting solution (Life Technologies, Prolong® Gold Antifade reagent 
with DAPI, P36935). Fluorescence images were acquired using a confocal microscope (LSM 710, Carl 
Zeiss) equipped with a 63x and a 40x oil immersion 1.4 objective. Image analysis was performed using 
FIJI or ImageJ. The mean fluorescence intensity per blastocyst was measured as the ratio between the 
average mean fluorescent intensity of the projected z-stack image of each embryo and the selected area. 
 
Gene Expression Analysis by Quantitative PCR with Reverse Transcription. Total RNA was 
isolated using the ARCTURUS® PicoPure® RNA Isolation Kit (Life Technologies, Invitrogen) 
according to the manufacturer’s protocol, and including an on-column DNase digestion (Qiagen, 
79254). Reverse transcription was performed using the SuperScript VILO cDNA synthesis kit 
(Invitrogen, 11754-250) according to the manufacturer’s instructions. Real-time quantitative PCRs 
were performed using the ABI Power SYBR Green Master Mix (Applied Biosystems, 4309155). PCR 
reactions were run on a ViiA7 machine (Applied Biosystems) and results were analysed using the 
	  ViiATM7 – software 1.1. An endogenous control (Gapdh, glyceraldehyde-3-phosphate dehydrogenase) 
was used to normalize the expression. Technical replicates were carried out for all quantitative PCR 
reactions. The following primers were used:  c-myc-FW, 5’-CAC CAG CAG CGA CTC TGA-3’; c-
myc-RV, 5’-GGG GTT TGC CTC TTC TCC-3’; N-myc-FW, 5’-CTC CGG AGA GGA TAC CTT 
GA-3’; N-myc-RV, 5’-TCT CTA CGG TGA CCA CAT CG-3’; Gapdh-FW, 5’-CCC ATT CTC GGC 
CTT GAC TGT-3’; Gapdh-RV, 5’- GTG GAG ATT GTT GCC ATC AAC GA-3’. 
 
RNA-seq. Total RNA isolation was performed from 12 samples using ARCTURUS® PicoPure® RNA 
Isolation Kit (Life Technologies, Invitrogen) according to the manufacturer’s instructions. DNAse 
treatment was performed using RNAse-free DNAse Set (Qiagen). Total RNA was used for quality 
controls and for normalization of starting material. cDNA-libraries were generated with 10 ng of total 
RNA using the SMARTer™ Ultra Low RNA Kit for Illumina Sequencing (Clontech) according to the 
manufacturer’s indications. Twelve cycles were used for the amplification of cDNA. The sequencing 
library was generated using the NEB Next ChIP-Seq kit according to manufacturer’s instructions (New 
England Biolabs). Sequencing reads (100 bp) were generated on the HiSeq2000 platform (Illumina) 
with three samples per lane. Processing of RNA-seq data was performed as previously described 
(Cabezas-Wallscheid et al., 2014). The sequenced read fragments were aligned to the mouse reference 
genome GRCm38 (ENSEMBL release 69) (Cunningham et al., 2015) using GSNAP (version 2012-07-
20). The number of read fragments overlapping with each gene were counted using HTSeq (Anders et 
al., 2015). DESeq2 (Love et al., 2014) was used to test for differential expression. Relative expression 
levels for each gene were calculated from the read counts after applying a variance stabilizing 
transformation by estimating the ratio between the mean across replicates for a specific cell population 
to the mean across all the samples. Genes were grouped based on the sign of their relative expression 
level (Figure S2D). Gene set enrichment analysis was done as previously described (Cabezas-
Wallscheid et al., 2014).  The raw data are deposited to ArrayExpress 
(http://www.ebi.ac.uk/arrayexpress) and are available under the accession E-MTAB-3386. In Data S1, 
we provide the documented R scripts that were used to analyse the high-throughput transcriptome data. 
 
Microarray Analysis. Total RNA isolation was performed using ARCTURUS® PicoPure® RNA 
Isolation Kit (Life Technologies, Invitrogen) according to the manufacturer’s instructions. DNAse 
treatment was performed using RNAse-free DNAse Set (Qiagen). Microarray analysis raw data are 
available for download from Gene Expression Omnibus (http://ncbi.nlm.nih.gov/geo; gene accession 
number: GSE74337). Microarray gene-expression analysis was made using the GeneChip® Mouse 
Genome 430 2.0 Array (Affymetrix, Santa Clara, CA, USA). Both raw image (.dat) and intensity (.cel) 
files were generated utilizing the Affymetrix Gene Chip Operating Software (GCOS). Quality control 
and RMA background subtraction, quantile normalization and summarization of the intensity data have 
been performed with the oligo package under the R statistical software (http://www.r-project.org). 
DEG have been calculated using the limma package and genes with a FDR<0.05 and with a log2 fold 
change of at least 0.5 have been selected for further analysis. GO-term characterization has been 
performed with the GOstats package. 
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